BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25312710)

  • 21. MicroRNAs in the pathogenesis of neuroblastoma.
    Schulte JH; Horn S; Schlierf S; Schramm A; Heukamp LC; Christiansen H; Buettner R; Berwanger B; Eggert A
    Cancer Lett; 2009 Feb; 274(1):10-5. PubMed ID: 18639376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs in personalized cancer therapy.
    Sethi S; Ali S; Sethi S; Sarkar FH
    Clin Genet; 2014 Jul; 86(1):68-73. PubMed ID: 24635652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
    Kogner P; Barbany G; Dominici C; Castello MA; Raschellá G; Persson H
    Cancer Res; 1993 May; 53(9):2044-50. PubMed ID: 8481906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
    Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
    Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Involvement of microRNAs in cancer biology and possibilities of their application to diagnostic and predictive oncology].
    Slabý O; Krekác D; Hrstka R; Svoboda M; Vyzula R
    Cas Lek Cesk; 2008; 147(1):25-31. PubMed ID: 18323039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of microRNAs in hematological malignancies.
    Fatica A; Bozzoni I
    Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of expression profiling of circulating microRNAs in men with prostate cancer.
    Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
    BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs: Essential players in the regulation of inflammation.
    Rebane A; Akdis CA
    J Allergy Clin Immunol; 2013 Jul; 132(1):15-26. PubMed ID: 23726263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs in gastrointestinal malignancy: a tool in cancer prevention?
    Mactier KE; Glaire MA; Basavaraju U; El-Omar EM; Hold GL
    Eur J Cancer Prev; 2014 Nov; 23(6):540-9. PubMed ID: 24608603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroblastoma: What the nurse practitioner should know.
    Mazur KA
    J Am Acad Nurse Pract; 2010 May; 22(5):236-45. PubMed ID: 20500737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress towards personalized therapeutics: biologic- and risk-directed therapy for neuroblastoma.
    Gustafson WC; Matthay KK
    Expert Rev Neurother; 2011 Oct; 11(10):1411-23. PubMed ID: 21955198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A.
    Yang H; Li Q; Zhao W; Yuan D; Zhao H; Zhou Y
    FEBS Lett; 2014 Jan; 588(1):192-7. PubMed ID: 24316513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in the diagnosis and treatment of neuroblastoma].
    Kavan P; Koutecký J
    Cas Lek Cesk; 1998 Apr; 137(8):231-6. PubMed ID: 9650346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management strategy in neuroblastoma].
    Balwierz W
    Przegl Lek; 2004; 61 Suppl 2():3-8. PubMed ID: 15686038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of the most common solid tumors in childhood.
    Marina NM; Krance R; Ribeiro RC; Crist WM
    Prim Care; 1992 Dec; 19(4):871-89. PubMed ID: 1334564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical aspects of microRNA in diagnostics: a review.
    de Planell-Saguer M; Rodicio MC
    Anal Chim Acta; 2011 Aug; 699(2):134-52. PubMed ID: 21704768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroblastoma as a neurobiological disease.
    Schor NF
    J Neurooncol; 1999 Jan; 41(2):159-66. PubMed ID: 10222436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response.
    Iborra M; Bernuzzi F; Invernizzi P; Danese S
    Autoimmun Rev; 2012 Mar; 11(5):305-14. PubMed ID: 20627134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroblastoma: a clinical challenge and biologic puzzle.
    Matthay KK
    CA Cancer J Clin; 1995; 45(3):179-92. PubMed ID: 7743421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Novel micro RNA-based therapies for the treatment of neuroblastoma].
    Boloix A; París-Coderch L; Soriano A; Roma J; Gallego S; Sánchez de Toledo J; Segura MF
    An Pediatr (Barc); 2016 Aug; 85(2):109.e1-109.e6. PubMed ID: 26323526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.